The short-term bronchodilator effects of the dual phosphodiesterase 3 and 4 inhibitor RPL554 in COPD

We investigated the short-term bronchodilator effects of RPL554 (an inhaled dual phosphodiesterase 3 and 4 inhibitor) combined with other bronchodilators in chronic obstructive pulmonary disease patients with reversibility (>150 mL to short-acting bronchodilators). Study 1 was a six-way, placebo-...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Dave, Abbott-Banner, Katharine, Bengtsson, Thomas, Newman, Kenneth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6214575/
https://www.ncbi.nlm.nih.gov/pubmed/30166326
http://dx.doi.org/10.1183/13993003.01074-2018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6214575/
https://www.ncbi.nlm.nih.gov/pubmed/30166326
http://dx.doi.org/10.1183/13993003.01074-2018

Ejemplares similares